Long-Haul COVID: Blood Test Could Predict Lung Problems
Researchers have discovered a potential way to predict which patients are likely to suffer long-haul COVID and associated lung problems.
Researchers have discovered a potential way to predict which patients are likely to suffer long-haul COVID and associated lung problems.
A new study found that brain injury markers are present in the blood months after COVID infection, despite normal inflammation blood tests.
The prototype device uses lab-on-a-chip technology and has been proven to provide rapid and low-cost detection of COVID from nasal swabs.
Repeat testing with antigen tests reduces false-negative results, leading the FDA to update its testing recommendations.
Read MoreBiobot Analytics is launching a respiratory illnesses panel that will include wastewater monitoring for the seasonal flu, RSV, and COVID.
Read MoreWhere did the COVID-19 outbreak originate? Angus Dalgleish, PhD, shows that the virus that emerged in Wuhan, China, in 2019.
Read MoreA new survey found that clinical labs’ response to COVID helped to contain the virus and save lives, though new challenges have since arisen.
Read MoreAbbott’s ID NOW 2.0 point-of-care diagnostic testing platform received 510K clearance and CLIA waiver from the U.S. FDA.
Read MoreiHealth Labs, a provider of at-home COVID tests, announced its manufacturing facility for COVID tests manufactured over 70 million test kits.
Read MoreSensible Diagnostics was selected by the RADx Tech program launched by the NIBIB, which is part of the National Institutes of Health (NIH).
Read MoreThe new COVID detection method employs equipment already being used in hospitals and labs to detect bacterial and fungal infections.
Read MoreRecent studies have highlighted the power of dogs in detecting COVID, even when obscured by other viruses, such as common colds and the flu.
Read MoreScientists developed a breath test that quickly identifies those who are infected with the virus that causes COVID.
Read MoreSEKISUI Diagnostics announced the launch of the OSOM COVID-19 Antigen Home Test to diagnose COVID-19 at home.
Read MoreThe new biochip offers the potential to test multiple pathogens responsible for respiratory infections, such as COVID, RSV, and influenza.
Read MoreResearchers developed a nano-immune magnetic bead that can efficiently be bound to SARS-CoV-2 pseudovirus.
Read MoreNew data provides a unique snapshot of the interplay among SARS-CoV-2, influenza, and respiratory syncytial virus (RSV).
Read MoreA team of RADx Tech and accessibility experts are actively working with the test manufacturer hopefuls to address the design of COVID tests.
Read More